Official Title
SARS-CoV2 (COVID-19) Seroepidemiological Investigation in Transplanted Population Subjects of Kidney, Kidney-pancreas, Isolated Pancreas, Langerhans Islets
Brief Summary

Evaluate SARS-CoV2 infection and the degree of immunity possibly developed in transplanted population using the Luciferase Immuno Precipitation System (LIPS) test.

Status
Completed
Conditions
Kidney Transplant
Pancreatic Transplat
Pancreatic Islets Langerhans
Interventions

Procedure: blood sample for seroepidemiological investigation

blood sample for seroepidemiological investigation

Eligibility Criteria

Inclusion Criteria Cohort 1:

- Adult patients (age ≥ 18 years),

- Kidney or pancreas or pancreatic islets transplantation

- Transplanted patients (period: 01.01.2020 to 30.06.2020)

- Informed Consent signed

Inclusion Criteria Cohort 2:

- Adult patients (age ≥ 18 years),

- Kidney or pancreas or pancreatic islets transplantation

- transplanted patients in follow-up since 01.01.2020 or trasplanted patients after
30.06.2020.

- Informed Consent signed

Exclusion Criteria both Cohort (1&2):

Symptomatology such as fever> 37.5, and / or cough and / or respiratory distress and / or
diarrhea / vomiting in 14 days prior to collection of blood sample

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
Italy
Locations

IRCCS San Raffaele
Milan, Italy

Sponsors / Collaborators
Antonio Secchi
NCT Number
NCT04487197
Keywords
COVID-19 infection
Transplanted patients
kidney transplants
pancreas transplants
pancreatic islet transplantation
MeSH Terms
COVID-19